Putting the Brakes on SARS-CoV-2: Neutralizing Antibodies
Tue, Jul 28, 2020 · 2:35 PM
ABOUT THIS WEBINAR
SARS-CoV-2 is characterized by its rapid spread and significant human-to-human transmission. With no approved vaccines or treatments yet available, researchers are exploring various medical interventions including neutralizing monoclonal antibodies (mAbs) to control the global COVID-19 pandemic. The SARS-CoV-2 spike (S) glycoprotein, which promotes entry into host cells, is the main target of neutralizing antibodies. In this multisponsored webinar by The Scientist, a panel of researchers will discuss potential neutralizing antibodies currently under investigation for SARS-CoV-2 treatment.
Topics to be covered
- Human monoclonal antibodies for SARS-CoV-2
- SARS-CoV-2 neutralizing antibodies for global access
Thanks to our sponsors
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant antigen production and antibody development. Sino Biological is dedicated to virology and infectious disease research. Its ProVir™ collection is the world’s largest viral antigen bank, carrying over 800 products from 350 strains of viruses. Sino Biological is the first company in the world to produce the SARS-CoV-2 viral antigens. To support the development of immunodiagnostic assay, Sino Biological has developed a comprehensive collection of antigens and antibodies for SARS-CoV-2. These reagents have already been used to manufacture FDA-approved diagnostic kits in the US. For more information, please visit www.sinobiological.com.
Absolute Antibody is a rapidly growing company with a vision to make recombinant antibody technology accessible to all. We offer antibody sequencing, engineering and recombinant production as custom services, as well as a unique catalog of recombinant antibodies, engineered into new and useful formats.
Thermo Fisher Scientific
At Thermo Fisher Scientific, our mission is to enable our customers to make the world healthier, cleaner and safer. The global coronavirus (COVID-19) outbreak is a powerful reminder of the importance of that mission. We are profoundly aware of our obligations to help ensure the safety of our colleagues, continue supporting our customers and leverage our capabilities to address this rapidly evolving public health crisis. Thermo Fisher is at the heart of the global response to COVID-19. We are working with government agencies and researchers to ensure priority access to instruments, consumables, safety supplies and other products to address the outbreak–particularly in analysis of the virus, diagnosis and personal protection. Find out more at thermofisher.com/coronavirus
At Twist Bioscience, we work in service of people who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, our unique silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers.
ACROBiosystems is a leading manufacturer of recombinant proteins and other critical reagents
to support the development of target therapeutics and diagnostic kits. To facilitate research on SARS-CoV-2 and help fighting against COVID-19 pandemic, ACROBiosystems has developed more than 60 SARS-CoV-2 related products within which about two thirds are recombinant SARS-CoV-2 antigens with multiple tags & species mostly expressed by HEK293, covering all the critical targets of SARS-CoV-2.
10x Genomics builds solutions to interrogate biological systems at a resolution and scale that matches the complexity of biology. Our rapidly expanding suite of products, which include instruments, consumables, and software, have enabled customers to make fundamental discoveries across multiple research areas, including cancer, immunology, and neuroscience.
BPS Bioscience is a US based, original manufacturer with an innovative portfolio of over 4000 products to assist in your drug discovery projects. As a primary manufacturer, BPS can supply products in large-scale bulk quantities and welcomes inquiries for contract and custom manufacturing within a variety of research areas.
Director, Vanderbilt Vaccine Center, Professor, Pediatrics and Pathology, Microbiology and Immunology, Ann Scott Carrell Chair
Dr. James Crowe is Director of the Vanderbilt Vaccine Center and the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology at Vanderbilt. His laboratory studies the human immune response to infection for a wide variety...
Director of Product Discovery and Optimization, IAVI
Dr. Joseph Jardine is the Director of Product Discovery and Optimization for IAVI based at Scripps Research. He is generally interested in the discovery and development of antibodies, nanobodies and other protein-based therapeutics that can be...